P-6100
Blood Advances | 2025
Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel.
Locke FL, Siddiqi T, Jacobson CA, Nikiforow S, Ahmed S, Miklos DB, Lin Y, Lunning MA, Hill BT, Ghobadi A, Hu ZH, Hemmer MT, Zoratti MJ, Vunnum S, Tsang J, Spooner C, Smith H, Fu C, Patel A, Miao H, Shahani SA, Mirjah DL, Xu H, Pasquini MC
PubMed
PMID: 39883946
CIBMTR Study #: SC17-07f